Routine Dental Care (Preventive Care)

Routine dental care, also known as preventive care, refers to dental services that are meant to maintain oral health and prevent dental problems. These services are typically covered by dental insurance plans and include regular check-ups, cleanings, and x-rays.  

Key features of routine dental care in insurance include:

  • Covered services: Preventive dental care services, such as oral exams, cleanings, and x-rays, are typically covered by dental insurance plans.

  • Importance of prevention: The emphasis on preventive care is to prevent dental problems from developing or getting worse.

  • Frequency of visits: The frequency of visits for preventive care is typically twice a year or every six months.

  • Cost-sharing: Some dental insurance plans may require cost-sharing for preventive care services, such as a copayment or coinsurance.

  • Annual limits: Dental insurance plans may have annual limits on the number of preventive care services that are covered.

Example: A dental insurance plan may cover two routine dental check-ups and cleanings per year, with no cost-sharing required for the patient. The plan may also cover one set of x-rays per year. The purpose of these services is to detect and prevent dental problems such as cavities, gum disease, and oral cancer.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.